Cargando…
Drivers of Esophageal Adenocarcinoma and Opportunities for Cancer Interception
Autor principal: | Garman, Katherine S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348867/ https://www.ncbi.nlm.nih.gov/pubmed/34029533 http://dx.doi.org/10.1016/j.jcmgh.2021.04.018 |
Ejemplares similares
-
Therapeutic Interception of Early Lung Adenocarcinoma Progression:
Not Just How, but When?
por: Borczuk, Alain C.
Publicado: (2021) -
Interception of Signaling Circuits of Esophageal Adenocarcinoma Cells by Resveratrol Reveals Molecular and Immunomodulatory Signatures
por: Dhir, Hardika, et al.
Publicado: (2021) -
Interceptive Orthodontics and Temporomandibular Joint Adaptations: Such Evidences?
por: Tecco, Simona, et al.
Publicado: (2017) -
A broader look at Interceptive Orthodontics: What can we offer?
por: Artese, Flavia
Publicado: (2019) -
Esophageal Adenocarcinoma: Opportunities for Targeted Prevention in
Ohio
por: Stephens, Julie A, et al.
Publicado: (2018)